Login

Mr Karolis Rosickas, CEO, Regeneus Ltd 00:00:00

Share On Facebook Share On Twitter

Karolis was appointed CEO of Regeneus on 2 November 2020.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Korian, Derichebourg, Alstom, TotalEnergies, Somfy... on répond à vos besoins : Louis Aliot répond à Jules Koundé après sa prise de position, suggesting a response to Jules Koundé's stance.
00:10:00
Surefire Resources' Victory Bore Vanadium Project: A World-Class Asset with Significant Potential
00:10:00
Therese Tucker of BlackLine Talks About the Intersection of Accounting and Technology | Therese Tucker, CEO, BlackLine Inc.
00:10:00
Navigating Forfait Taxation in Switzerland: An Overview by Valerie Geiser | Valerie Geiser - Director of Stonehage
00:10:00
Gary Harris on Navigating Market Cycles and Client-Centric Investment Strategies
00:10:00
Cleary Gottlieb Receives 2016 Pro Bono Publico Award | Michael L. Ryan - Senior Counsel of Cleary Gottlieb Steen & Hamilton LLP
00:10:00
Yuval Levin on Institutions and Trust in America|Yuval Levin
00:10:00
Canadian Gold Corp's Tartan Lake Project: A Deep Dive into Potential High-Grade Gold Deposits
00:10:00
"Global Leadership in Asset Management: Insights from Laurence D. Fink of BlackRock | Laurence D. Fink - Chairman & CEO, BlackRock, Inc."
00:10:00
DLTx's website hosts interviews with key figures like James Haft, Chairman, and Joe Davy, Founder, Chairman, emphasizing insights into their blockchain initiatives.
00:10:00
Exploring the Long-Term Growth Potential of Diverse Royalty Assets | Brian Dalton , CEO, Altius Minerals Corp.
00:10:00
Strategies for Managing Risk and Return in Private Equity | John Connaughton, Co-Managing Partner , Bain Capital .

© 2017 - Neuhu+